MedTrace Logo

Efficacy Study of EVT 201 to Treat Insomnia

NCT00380003 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2008-01-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).

Conditions

  • Sleep Initiation and Maintenance Disorders

Interventions

DRUG

EVT 201

Sponsors & Collaborators

  • Evotec Neurosciences GmbH

    lead INDUSTRY

Principal Investigators

  • James K Walsh, PhD · St. Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, MI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380003 on ClinicalTrials.gov